Shares of the life sciences SPAC are expected to begin trading today on the NYSE under “CHFW.U”. View notice.
Related Posts
Frontier Investment Adjourns Extension Vote Again
The SPAC’s current termination deadline is July 6. The extension proposal, if approved, would move the deadline to July 2024.
Health Sciences Acquisitions 2 Files Prelim Proxy for Deadline Extension
The SPAC raised $160 million in its August 2020 IPO with the goal of acquiring a company in North America or Europe that is developing assets in the biopharma and medical technology sectors.
Sierra Lake Acquisition Terminates Monthly $10K Support Agreement with Sponsor
The parties also agreed to waive all fees owed by the SPAC under the agreement.
Northview Acquisition Trims Deal Size 17% Ahead of $150M IPO
The SPAC expects to target small-cap healthcare companies that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space.